Clinical Trial Update: Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Tegafur-Uracil to observation in patients with stage II colorectal cancer that has been completely removed by surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Tegafur-Uracil (tegafur-uracil)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED